Bausch Health Companies (BHC) R&D In Process (2016 - 2019)
Historic R&D In Process for Bausch Health Companies (BHC) over the last 10 years, with Q1 2019 value amounting to $1.0 million.
- Bausch Health Companies' R&D In Process changed 0.0% to $1.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $18.0 million, marking a year-over-year decrease of 4705.88%. This contributed to the annual value of $1.0 million for FY2018, which is 8000.0% down from last year.
- Bausch Health Companies' R&D In Process amounted to $1.0 million in Q1 2019, which was down 0.0% from $1.0 million recorded in Q1 2018.
- Bausch Health Companies' R&D In Process' 5-year high stood at $95.8 million during Q3 2015, with a 5-year trough of -$20.0 million in Q4 2016.
- For the 4-year period, Bausch Health Companies' R&D In Process averaged around $16.2 million, with its median value being $1.0 million (2016).
- In the last 5 years, Bausch Health Companies' R&D In Process soared by 38140.7% in 2015 and then crashed by 85238.1% in 2016.
- Bausch Health Companies' R&D In Process (Quarter) stood at -$2.1 million in 2015, then crashed by 852.38% to -$20.0 million in 2016, then skyrocketed by 105.0% to $1.0 million in 2018, then changed by 0.0% to $1.0 million in 2019.
- Its R&D In Process stands at $1.0 million for Q1 2019, versus $1.0 million for Q1 2018 and -$20.0 million for Q4 2016.